Infliximab in Ankylosing Spondylitis Associated With Chronic Hepatitis B Infection. Role of Lamivudine Therapy
Infliximab en la espondilitis anquilosante asociada a infección crónica por el virus de la hepatitis B. Papel del tratamiento con lamivudina
Jesús Sanz Sanz
, Lucía Silva Fernández, José Luis Calleja Panero, Mónica Fernández-Castro, José Luis Andreu Sánchez
Servicio de Reumatología, Hospital Universitario Puerta de Hierro, Madrid, Spain
Leído
6001
Vecesse ha leído el artículo
2739
Total PDF
3262
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 3 | 5 | 8 |
| 2025 5 | 81 | 95 | 176 |
| 2025 4 | 62 | 27 | 89 |
| 2025 3 | 61 | 29 | 90 |
| 2025 2 | 41 | 25 | 66 |
| 2025 1 | 39 | 73 | 112 |
| 2024 12 | 28 | 33 | 61 |
| 2024 11 | 35 | 76 | 111 |
| 2024 10 | 20 | 36 | 56 |
| 2024 9 | 30 | 22 | 52 |
| 2024 8 | 39 | 36 | 75 |
| 2024 7 | 27 | 30 | 57 |
| 2024 6 | 38 | 38 | 76 |
| 2024 5 | 36 | 42 | 78 |
| 2024 4 | 29 | 22 | 51 |
| 2024 3 | 32 | 49 | 81 |
| 2024 2 | 24 | 26 | 50 |
| 2024 1 | 22 | 21 | 43 |
| 2023 12 | 16 | 37 | 53 |
| 2023 11 | 21 | 25 | 46 |
| 2023 10 | 17 | 35 | 52 |
| 2023 9 | 25 | 36 | 61 |
| 2023 8 | 18 | 16 | 34 |
| 2023 7 | 18 | 39 | 57 |
| 2023 6 | 19 | 20 | 39 |
| 2023 5 | 17 | 10 | 27 |
| 2023 4 | 11 | 11 | 22 |
| 2023 3 | 30 | 31 | 61 |
| 2023 2 | 24 | 26 | 50 |
| 2022 1 | 17 | 18 | 35 |
| 2022 12 | 21 | 28 | 49 |
| 2022 11 | 27 | 22 | 49 |
| 2022 10 | 23 | 23 | 46 |
| 2022 9 | 21 | 28 | 49 |
| 2022 8 | 24 | 44 | 68 |
| 2022 7 | 24 | 43 | 67 |
| 2022 6 | 19 | 21 | 40 |
| 2022 5 | 24 | 53 | 77 |
| 2022 4 | 29 | 43 | 72 |
| 2022 3 | 33 | 45 | 78 |
| 2022 2 | 31 | 38 | 69 |
| 2021 1 | 38 | 38 | 76 |
| 2021 12 | 16 | 42 | 58 |
| 2021 11 | 30 | 44 | 74 |
| 2021 10 | 75 | 46 | 121 |
| 2021 9 | 30 | 44 | 74 |
| 2021 8 | 23 | 40 | 63 |
| 2021 7 | 24 | 30 | 54 |
| 2021 6 | 23 | 46 | 69 |
| 2021 5 | 23 | 34 | 57 |
| 2021 4 | 54 | 77 | 131 |
| 2021 3 | 58 | 30 | 88 |
| 2021 2 | 33 | 22 | 55 |
| 2020 1 | 26 | 27 | 53 |
| 2020 12 | 32 | 24 | 56 |
| 2020 11 | 17 | 18 | 35 |
| 2020 10 | 19 | 7 | 26 |
| 2020 9 | 18 | 28 | 46 |
| 2020 8 | 15 | 15 | 30 |
| 2020 7 | 22 | 18 | 40 |
| 2020 6 | 18 | 21 | 39 |
| 2020 5 | 18 | 18 | 36 |
| 2020 4 | 16 | 17 | 33 |
| 2020 3 | 12 | 6 | 18 |
| 2020 2 | 3 | 0 | 3 |
| 2020 1 | 2 | 0 | 2 |
| 2019 8 | 1 | 0 | 1 |
| 2019 7 | 1 | 0 | 1 |
| 2019 3 | 2 | 0 | 2 |
| 2018 12 | 1 | 0 | 1 |
| 2018 5 | 4 | 2 | 6 |
| 2018 4 | 23 | 14 | 37 |
| 2018 3 | 33 | 19 | 52 |
| 2018 2 | 9 | 6 | 15 |
| 2018 1 | 14 | 4 | 18 |
| 2017 12 | 12 | 9 | 21 |
| 2017 11 | 11 | 7 | 18 |
| 2017 10 | 11 | 5 | 16 |
| 2017 9 | 10 | 6 | 16 |
| 2017 8 | 9 | 16 | 25 |
| 2017 7 | 13 | 13 | 26 |
| 2017 6 | 25 | 11 | 36 |
| 2017 5 | 26 | 10 | 36 |
| 2017 4 | 22 | 6 | 28 |
| 2017 3 | 17 | 18 | 35 |
| 2017 2 | 8 | 4 | 12 |
| 2016 1 | 11 | 7 | 18 |
| 2016 12 | 30 | 15 | 45 |
| 2016 11 | 22 | 8 | 30 |
| 2016 10 | 29 | 6 | 35 |
| 2016 9 | 31 | 15 | 46 |
| 2016 8 | 25 | 7 | 32 |
| 2016 7 | 11 | 3 | 14 |
| 2016 2 | 1 | 0 | 1 |
| 2015 1 | 1 | 0 | 1 |
| 2015 12 | 2 | 0 | 2 |
| 2015 10 | 3 | 0 | 3 |
| 2015 7 | 21 | 6 | 27 |
| 2015 6 | 21 | 12 | 33 |
| 2015 5 | 31 | 22 | 53 |
| 2015 4 | 22 | 17 | 39 |
| 2015 3 | 38 | 13 | 51 |
| 2015 2 | 30 | 15 | 45 |
| 2015 1 | 14 | 15 | 29 |
| 2014 12 | 22 | 13 | 35 |
| 2014 11 | 19 | 11 | 30 |
| 2014 10 | 21 | 14 | 35 |
| 2014 9 | 19 | 13 | 32 |
| 2014 8 | 28 | 17 | 45 |
| 2014 7 | 18 | 15 | 33 |
| 2014 6 | 44 | 7 | 51 |
| 2014 5 | 33 | 27 | 60 |
| 2014 4 | 46 | 11 | 57 |
| 2014 3 | 40 | 17 | 57 |
| 2014 2 | 32 | 12 | 44 |
| 2014 1 | 36 | 18 | 54 |
| 2013 12 | 25 | 9 | 34 |
| 2013 11 | 28 | 9 | 37 |
| 2013 10 | 26 | 12 | 38 |
| 2013 9 | 27 | 14 | 41 |
| 2013 8 | 28 | 14 | 42 |
| 2013 7 | 23 | 6 | 29 |
| 2013 6 | 23 | 16 | 39 |
| 2013 5 | 19 | 14 | 33 |
| 2013 4 | 31 | 15 | 46 |
| 2013 3 | 23 | 14 | 37 |
| 2013 2 | 13 | 15 | 28 |
| 2013 1 | 21 | 12 | 33 |
| 2012 12 | 9 | 12 | 21 |
| 2012 11 | 2 | 8 | 10 |
| 2012 10 | 9 | 9 | 18 |
| 2012 9 | 8 | 5 | 13 |
| 2012 6 | 1 | 0 | 1 |
| 2012 5 | 1 | 0 | 1 |
| 2012 4 | 6 | 0 | 6 |
| 2012 3 | 2 | 0 | 2 |
| 2012 2 | 3 | 0 | 3 |
| 2011 1 | 4 | 0 | 4 |
| 2011 12 | 2 | 0 | 2 |
| 2011 11 | 5 | 0 | 5 |
| 2011 10 | 1 | 0 | 1 |
| 2011 9 | 1 | 0 | 1 |
| 2011 8 | 1 | 0 | 1 |
| 2011 7 | 3 | 0 | 3 |
| 2011 6 | 3 | 0 | 3 |
| 2011 5 | 1 | 0 | 1 |
| 2011 3 | 2 | 0 | 2 |
| 2011 2 | 2 | 0 | 2 |
| 2010 1 | 4 | 0 | 4 |
| 2010 12 | 4 | 0 | 4 |
| 2010 11 | 8 | 0 | 8 |
| 2010 10 | 5 | 0 | 5 |
| 2010 9 | 6 | 0 | 6 |
| 2010 8 | 4 | 0 | 4 |
| 2010 7 | 4 | 0 | 4 |
| 2010 6 | 2 | 0 | 2 |
| 2010 5 | 9 | 0 | 9 |
| 2010 4 | 7 | 0 | 7 |
| 2010 3 | 5 | 0 | 5 |
| 2010 2 | 7 | 0 | 7 |
| 2009 1 | 1 | 0 | 1 |
| 2009 12 | 5 | 0 | 5 |
| 2009 11 | 18 | 0 | 18 |
| 2009 10 | 7 | 0 | 7 |
| 2009 9 | 7 | 0 | 7 |
| 2009 8 | 5 | 0 | 5 |
| 2009 7 | 6 | 0 | 6 |
| 2009 6 | 5 | 0 | 5 |
| 2009 5 | 9 | 0 | 9 |
| 2009 4 | 19 | 0 | 19 |
| 2009 3 | 8 | 0 | 8 |
Mostrar todo
